You must log in to view this page.

Kailera Therapeutics Inc. – Filings and Transcripts

NASDAQ: KLRA
Share price (11/6/26): $12.97
Market cap (11/6/26): $1.684 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 03/31/26 Q1

Prospectuses and Registrations Filter

Prospectus supplement with pricing info

Registration of securities for employees

Addition of securities to prior initial registration

Registration of securities on exchange

Initial registration of new securities – amended

Ownership Filter

Rtw Investments, LP

Canada Pension Plan Investment Board

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

News Filter

Reports Third Quarter 2026 Financial Results and Provides Business Updates

Reports Second Quarter 2026 Financial Results and Provides Business Updates

Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Other Events, Financial Statements or Exhibits

Proxies

No filings in this category.

Other Filter

Notice of effectiveness